Gamma knife radiosurgery for prolactinomas

被引:107
作者
Landolt, AM [1 ]
Lomax, N [1 ]
机构
[1] Klin Park, Gamma Knife Ctr, Neurosurg Sect, CH-8002 Zurich, Switzerland
关键词
pituitary neoplasm; dopamine agonists; prolactinoma; stereotactic radiosurgery; follow up;
D O I
10.3171/jns.2000.93.supplement_3.0014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Object. In this retrospective investigation the authors examined the results of gamma knife radiosurgery (GKS) for tumor remnants after unsuccessful open surgery and medical treatment in 20 patients with prolactinomas. Particular attention is paid to a possible radioprotective action of dopamine agonists similar to the action of octreotide in acromegaly. Methods. Twenty patients with prolactinomas were followed after GKS. Five patients were treated successfully; their prolactin (PRL) levels dropped into the normal range and dopaminergic drugs could be discontinued. Two spontaneous pregnancies were observed and 11 patients experienced improvement. Improvement was defined as normal PRL levels with the continued possibility of reduced medical treatment or a substantially reduced medical treatment dose with some degree of hyperprolactinemia maintained. The treatment failed in three patients who experienced no improvement. Patients treated with dopaminergic drugs during GKS did significantly less well in comparison with the untreated group when a cumulative distribution function (Kaplan-Meier estimate) was used. Conclusions. The results of GKS for prolactinomas in this investigation are better than the results published by others. This may be an effect of case selection because there were no "salvage cases" in our group of patients. Because a dopamine agonist seemed to induce radioprotection in this series, it is suggested that GKS be performed during an intermission in drug therapy when the dopamine agonist is discontinued.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 19 条
[1]  
Colin P, 1998, Cancer Radiother, V2, P207, DOI 10.1016/S1278-3218(98)89092-6
[2]  
FEEK CM, 1984, TRENDS DIAGNOSIS TRE, P235
[3]   Octreotide may act as a radioprotective agent in acromegaly [J].
Landolt, AM ;
Haller, D ;
Lomax, N ;
Scheib, S ;
Schubiger, O ;
Siegfried, J ;
Wellis, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03) :1287-1289
[4]   Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy [J].
Landolt, AM ;
Haller, D ;
Lomax, N ;
Scheib, S ;
Schubiger, O ;
Siegfried, J ;
Wellis, G .
JOURNAL OF NEUROSURGERY, 1998, 88 (06) :1002-1008
[5]  
LANDOLT AM, 1984, LANCET, V2, P111
[6]  
LANDOLT AM, 1981, FERTIL STERIL, V35, P620
[7]   Radiosurgery for pituitary tumors and craniopharyngiomas [J].
Laws, ER ;
Vance, ML .
NEUROSURGERY CLINICS OF NORTH AMERICA, 1999, 10 (02) :327-+
[8]   Four years' experiences in the treatment of pituitary adenomas with Gamma Knife radiosurgery [J].
Lim, YJ ;
Leem, W ;
Kim, TS ;
Rhee, BA ;
Kim, GK .
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 1998, 70 :95-109
[9]   CHRONIC TREATMENT WITH PARLODEL LAR OF PATIENTS WITH PROLACTIN-SECRETING TUMORS - DIFFERENT RESPONSIVENESS OF MICROPROLACTINOMAS AND MACROPROLACTINOMAS [J].
MARASCHINI, C ;
MORO, M ;
MASALA, A ;
TOJA, P ;
ALAGNA, S ;
BRUNANI, A ;
ROVASIO, PP ;
GINANNI, A ;
LANCRANJAN, I ;
CAVAGNINI, F .
ACTA ENDOCRINOLOGICA, 1991, 125 (05) :494-501
[10]   CONVENTIONAL FRACTIONATED RADIATION-THERAPY VS RADIOSURGERY FOR SELECTED BENIGN INTRACRANIAL LESIONS (ARTERIOVENOUS-MALFORMATIONS, PITUITARY-ADENOMAS, AND ACOUSTIC NEUROMAS) [J].
MARKS, LB .
JOURNAL OF NEURO-ONCOLOGY, 1993, 17 (03) :223-230